These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT. Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [Abstract] [Full Text] [Related]
3. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY. Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [Abstract] [Full Text] [Related]
4. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors]. Wu ZJ, Zhang YX, Wei H, Jia Q. Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2253-6. PubMed ID: 18001544 [Abstract] [Full Text] [Related]
5. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas. Iagaru A, Quon A, McDougall IR, Gambhir SS. Clin Nucl Med; 2006 Dec 28; 31(12):754-60. PubMed ID: 17117068 [Abstract] [Full Text] [Related]
6. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M. J Nucl Med; 2008 Feb 28; 49(2):195-200. PubMed ID: 18199607 [Abstract] [Full Text] [Related]
7. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R. Pediatr Blood Cancer; 2007 Dec 28; 49(7):901-5. PubMed ID: 17252575 [Abstract] [Full Text] [Related]
8. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging. Picchio M, Mangili G, Samanes Gajate AM, De Marzi P, Spinapolice EG, Mapelli P, Giovacchini G, Sigismondi C, Viganò R, Sironi S, Messa C. Nucl Med Commun; 2010 Jun 28; 31(6):506-12. PubMed ID: 20168262 [Abstract] [Full Text] [Related]
9. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ. J Clin Oncol; 2009 Oct 01; 27(28):4774-80. PubMed ID: 19720925 [Abstract] [Full Text] [Related]
10. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site. Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G. Q J Nucl Med Mol Imaging; 2006 Mar 01; 50(1):15-22. PubMed ID: 16557200 [Abstract] [Full Text] [Related]
11. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit. Wild D, Eyrich GK, Ciernik IF, Stoeckli SJ, Schuknecht B, Goerres GW. J Craniomaxillofac Surg; 2006 Jan 01; 34(1):9-16. PubMed ID: 16343913 [Abstract] [Full Text] [Related]
12. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. Castellucci P, Perrone AM, Picchio M, Ghi T, Farsad M, Nanni C, Messa C, Meriggiola MC, Pelusi G, Al-Nahhas A, Rubello D, Fazio F, Fanti S. Nucl Med Commun; 2007 Aug 01; 28(8):589-95. PubMed ID: 17625380 [Abstract] [Full Text] [Related]
13. Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim EE. Radiology; 2007 Dec 01; 245(3):839-47. PubMed ID: 18024454 [Abstract] [Full Text] [Related]
14. PET/CT for the staging and follow-up of patients with malignancies. Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. Eur J Radiol; 2009 Jun 01; 70(3):382-92. PubMed ID: 19406595 [Abstract] [Full Text] [Related]
15. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin. Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B. J Nucl Med; 2009 Apr 01; 50(4):506-12. PubMed ID: 19289438 [Abstract] [Full Text] [Related]
16. 18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients. Saif MW, Cornfeld D, Modarresifar H, Ojha B. J Gastrointestin Liver Dis; 2008 Jun 01; 17(2):173-8. PubMed ID: 18568138 [Abstract] [Full Text] [Related]
17. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Metser U, Even-Sapir E. Semin Nucl Med; 2007 May 01; 37(3):206-22. PubMed ID: 17418153 [Abstract] [Full Text] [Related]
18. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Bar-Shalom R, Kagna O, Israel O, Guralnik L. Cancer; 2008 Dec 01; 113(11):3213-21. PubMed ID: 18924145 [Abstract] [Full Text] [Related]
19. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy. Fagotti A, Fanfani F, Rossitto C, Lorusso D, De Gaetano AM, Giordano A, Vizzielli G, Scambia G. Oncology; 2008 Dec 01; 75(3-4):152-8. PubMed ID: 18827492 [Abstract] [Full Text] [Related]
20. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Hutchings M, Loft A, Hansen M, Pedersen LM, Berthelsen AK, Keiding S, D'Amore F, Boesen AM, Roemer L, Specht L. Haematologica; 2006 Apr 01; 91(4):482-9. PubMed ID: 16585015 [Abstract] [Full Text] [Related] Page: [Next] [New Search]